How will DuPont determine that its biotechnology research is conducted in an ethical way?
We have made a public commitment to be open and transparent. We routinely consult with biotechnology’s critics and proponents about the development of biotechnology products and we are make key safety information available to the public. We also have formed an independent panel to guide our actions, help us consider and address important issues, and guide and challenge us in the development, testing, and commercialization of new products based on biotechnology. The advisory panel will audit the progress DuPont makes and provide regular public reports.
